Global Testosterone Replacement Therapy Market Research Report 2025

Publication ID:

PB505253559

Publication Date:

May 13, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

The global market for Testosterone Replacement Therapy was valued at US$ 1405 million in the year 2024 and is projected to reach a revised size of US$ 1052 million by 2031, growing at a CAGR of -4.1% during the forecast period.
Testosterone replacement therapy (TRT) is a class of hormone replacement therapy in which androgens, often testosterone, are replaced. Testosterone replacement therapy (TRT) is an FDA-approved medical treatment for men of any age who have low testosterone, a hormone necessary for male sexual development.
Global Testosterone Replacement Therapy key players include AbbVie, Endo International, Eli lilly, Pfizer, Actavis (Allergan) etc. Global top five manufacturers hold a share over 70%. North America is the largest market, with a share over 80%, followed by Europe and Asia (Ex. China) , both have a share over 10% percent.
In terms of product, Gels is the largest segment, with a share over 60%. And in terms of application, the largest application is Clinics, followed by Hospitals.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Testosterone Replacement Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Testosterone Replacement Therapy.
The Testosterone Replacement Therapy market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Testosterone Replacement Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Testosterone Replacement Therapy manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
AbbVie
Endo International
Eli lilly
Pfizer
Actavis (Allergan)
Bayer
Novartis
Teva
Mylan
Upsher-Smith
Ferring Pharmaceuticals
Kyowa Kirin
Acerus Pharmaceuticals
Segment by Type
Gels
Injections
Patches
Other
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Testosterone Replacement Therapy manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Testosterone Replacement Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Testosterone Replacement Therapy Market Overview
1.1 Product Definition
1.2 Testosterone Replacement Therapy by Type
1.2.1 Global Testosterone Replacement Therapy Market Value Comparison by Type (2024 VS 2031)
1.2.2 Gels
1.2.3 Injections
1.2.4 Patches
1.2.5 Other
1.3 Testosterone Replacement Therapy by Application
1.3.1 Global Testosterone Replacement Therapy Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Testosterone Replacement Therapy Market Size Estimates and Forecasts
1.4.1 Global Testosterone Replacement Therapy Revenue 2020-2031
1.4.2 Global Testosterone Replacement Therapy Sales 2020-2031
1.4.3 Global Testosterone Replacement Therapy Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Testosterone Replacement Therapy Market Competition by Manufacturers
2.1 Global Testosterone Replacement Therapy Sales Market Share by Manufacturers (2020-2025)
2.2 Global Testosterone Replacement Therapy Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Testosterone Replacement Therapy Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Testosterone Replacement Therapy, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Testosterone Replacement Therapy, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Testosterone Replacement Therapy, Product Type & Application
2.7 Global Key Manufacturers of Testosterone Replacement Therapy, Date of Enter into This Industry
2.8 Global Testosterone Replacement Therapy Market Competitive Situation and Trends
2.8.1 Global Testosterone Replacement Therapy Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Testosterone Replacement Therapy Players Market Share by Revenue
2.8.3 Global Testosterone Replacement Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Testosterone Replacement Therapy Market Scenario by Region
3.1 Global Testosterone Replacement Therapy Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Testosterone Replacement Therapy Sales by Region: 2020-2031
3.2.1 Global Testosterone Replacement Therapy Sales by Region: 2020-2025
3.2.2 Global Testosterone Replacement Therapy Sales by Region: 2026-2031
3.3 Global Testosterone Replacement Therapy Revenue by Region: 2020-2031
3.3.1 Global Testosterone Replacement Therapy Revenue by Region: 2020-2025
3.3.2 Global Testosterone Replacement Therapy Revenue by Region: 2026-2031
3.4 North America Testosterone Replacement Therapy Market Facts & Figures by Country
3.4.1 North America Testosterone Replacement Therapy Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Testosterone Replacement Therapy Sales by Country (2020-2031)
3.4.3 North America Testosterone Replacement Therapy Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Testosterone Replacement Therapy Market Facts & Figures by Country
3.5.1 Europe Testosterone Replacement Therapy Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Testosterone Replacement Therapy Sales by Country (2020-2031)
3.5.3 Europe Testosterone Replacement Therapy Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Testosterone Replacement Therapy Market Facts & Figures by Region
3.6.1 Asia Pacific Testosterone Replacement Therapy Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Testosterone Replacement Therapy Sales by Region (2020-2031)
3.6.3 Asia Pacific Testosterone Replacement Therapy Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Testosterone Replacement Therapy Market Facts & Figures by Country
3.7.1 Latin America Testosterone Replacement Therapy Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Testosterone Replacement Therapy Sales by Country (2020-2031)
3.7.3 Latin America Testosterone Replacement Therapy Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Testosterone Replacement Therapy Market Facts & Figures by Country
3.8.1 Middle East and Africa Testosterone Replacement Therapy Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Testosterone Replacement Therapy Sales by Country (2020-2031)
3.8.3 Middle East and Africa Testosterone Replacement Therapy Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Testosterone Replacement Therapy Sales by Type (2020-2031)
4.1.1 Global Testosterone Replacement Therapy Sales by Type (2020-2025)
4.1.2 Global Testosterone Replacement Therapy Sales by Type (2026-2031)
4.1.3 Global Testosterone Replacement Therapy Sales Market Share by Type (2020-2031)
4.2 Global Testosterone Replacement Therapy Revenue by Type (2020-2031)
4.2.1 Global Testosterone Replacement Therapy Revenue by Type (2020-2025)
4.2.2 Global Testosterone Replacement Therapy Revenue by Type (2026-2031)
4.2.3 Global Testosterone Replacement Therapy Revenue Market Share by Type (2020-2031)
4.3 Global Testosterone Replacement Therapy Price by Type (2020-2031)
5 Segment by Application
5.1 Global Testosterone Replacement Therapy Sales by Application (2020-2031)
5.1.1 Global Testosterone Replacement Therapy Sales by Application (2020-2025)
5.1.2 Global Testosterone Replacement Therapy Sales by Application (2026-2031)
5.1.3 Global Testosterone Replacement Therapy Sales Market Share by Application (2020-2031)
5.2 Global Testosterone Replacement Therapy Revenue by Application (2020-2031)
5.2.1 Global Testosterone Replacement Therapy Revenue by Application (2020-2025)
5.2.2 Global Testosterone Replacement Therapy Revenue by Application (2026-2031)
5.2.3 Global Testosterone Replacement Therapy Revenue Market Share by Application (2020-2031)
5.3 Global Testosterone Replacement Therapy Price by Application (2020-2031)
6 Key Companies Profiled
6.1 AbbVie
6.1.1 AbbVie Company Information
6.1.2 AbbVie Description and Business Overview
6.1.3 AbbVie Testosterone Replacement Therapy Sales, Revenue and Gross Margin (2020-2025)
6.1.4 AbbVie Testosterone Replacement Therapy Product Portfolio
6.1.5 AbbVie Recent Developments/Updates
6.2 Endo International
6.2.1 Endo International Company Information
6.2.2 Endo International Description and Business Overview
6.2.3 Endo International Testosterone Replacement Therapy Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Endo International Testosterone Replacement Therapy Product Portfolio
6.2.5 Endo International Recent Developments/Updates
6.3 Eli lilly
6.3.1 Eli lilly Company Information
6.3.2 Eli lilly Description and Business Overview
6.3.3 Eli lilly Testosterone Replacement Therapy Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Eli lilly Testosterone Replacement Therapy Product Portfolio
6.3.5 Eli lilly Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Company Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Testosterone Replacement Therapy Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Pfizer Testosterone Replacement Therapy Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Actavis (Allergan)
6.5.1 Actavis (Allergan) Company Information
6.5.2 Actavis (Allergan) Description and Business Overview
6.5.3 Actavis (Allergan) Testosterone Replacement Therapy Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Actavis (Allergan) Testosterone Replacement Therapy Product Portfolio
6.5.5 Actavis (Allergan) Recent Developments/Updates
6.6 Bayer
6.6.1 Bayer Company Information
6.6.2 Bayer Description and Business Overview
6.6.3 Bayer Testosterone Replacement Therapy Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Bayer Testosterone Replacement Therapy Product Portfolio
6.6.5 Bayer Recent Developments/Updates
6.7 Novartis
6.7.1 Novartis Company Information
6.7.2 Novartis Description and Business Overview
6.7.3 Novartis Testosterone Replacement Therapy Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Novartis Testosterone Replacement Therapy Product Portfolio
6.7.5 Novartis Recent Developments/Updates
6.8 Teva
6.8.1 Teva Company Information
6.8.2 Teva Description and Business Overview
6.8.3 Teva Testosterone Replacement Therapy Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Teva Testosterone Replacement Therapy Product Portfolio
6.8.5 Teva Recent Developments/Updates
6.9 Mylan
6.9.1 Mylan Company Information
6.9.2 Mylan Description and Business Overview
6.9.3 Mylan Testosterone Replacement Therapy Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Mylan Testosterone Replacement Therapy Product Portfolio
6.9.5 Mylan Recent Developments/Updates
6.10 Upsher-Smith
6.10.1 Upsher-Smith Company Information
6.10.2 Upsher-Smith Description and Business Overview
6.10.3 Upsher-Smith Testosterone Replacement Therapy Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Upsher-Smith Testosterone Replacement Therapy Product Portfolio
6.10.5 Upsher-Smith Recent Developments/Updates
6.11 Ferring Pharmaceuticals
6.11.1 Ferring Pharmaceuticals Company Information
6.11.2 Ferring Pharmaceuticals Description and Business Overview
6.11.3 Ferring Pharmaceuticals Testosterone Replacement Therapy Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Ferring Pharmaceuticals Testosterone Replacement Therapy Product Portfolio
6.11.5 Ferring Pharmaceuticals Recent Developments/Updates
6.12 Kyowa Kirin
6.12.1 Kyowa Kirin Company Information
6.12.2 Kyowa Kirin Description and Business Overview
6.12.3 Kyowa Kirin Testosterone Replacement Therapy Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Kyowa Kirin Testosterone Replacement Therapy Product Portfolio
6.12.5 Kyowa Kirin Recent Developments/Updates
6.13 Acerus Pharmaceuticals
6.13.1 Acerus Pharmaceuticals Company Information
6.13.2 Acerus Pharmaceuticals Description and Business Overview
6.13.3 Acerus Pharmaceuticals Testosterone Replacement Therapy Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Acerus Pharmaceuticals Testosterone Replacement Therapy Product Portfolio
6.13.5 Acerus Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Testosterone Replacement Therapy Industry Chain Analysis
7.2 Testosterone Replacement Therapy Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Testosterone Replacement Therapy Production Mode & Process Analysis
7.4 Testosterone Replacement Therapy Sales and Marketing
7.4.1 Testosterone Replacement Therapy Sales Channels
7.4.2 Testosterone Replacement Therapy Distributors
7.5 Testosterone Replacement Therapy Customer Analysis
8 Testosterone Replacement Therapy Market Dynamics
8.1 Testosterone Replacement Therapy Industry Trends
8.2 Testosterone Replacement Therapy Market Drivers
8.3 Testosterone Replacement Therapy Market Challenges
8.4 Testosterone Replacement Therapy Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

AbbVie
Endo International
Eli lilly
Pfizer
Actavis (Allergan)
Bayer
Novartis
Teva
Mylan
Upsher-Smith
Ferring Pharmaceuticals
Kyowa Kirin
Acerus Pharmaceuticals

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂